|
- Sub: Summary of proceedings of the Meeting of the Debenture . . .
Sub: Summary of proceedings of the Meeting of the Debenture Holders (“the meeting”) for Early Redemption of Non-Convertible Debentures with principal outstanding amount of Rs 7 30 crores issued under: ISIN INE04Q907066 (Non-cumulative) and INE04Q907082 (Cumulative) of Dar Credit Capital Ltd (“the Company”)
- T LijtuvwxY Z[ 6T:;;88::9889 = gt;?@ABCBD E rs GH ,I#$%J
! " #$%$ '()*()++,- 0123+,45 67899:8:9";<8" =>?@ABCBD E CF GH ,I#$%J : KL%HMNO4'PQRS- 67899:8T8U:88" =>?@ABCBD E CF GH ,I#$%J 9 #$%$ 'VRWXRY Z[ 67899:8";;"U8
- Ammonium is the preferred source of nitrogen for planktonic . . .
The sections used for TEM imaging were first coated with ca 10 nm of gold, before analysis with a Cameca NanoSIMS 50L ion microprobe Sections of O universa were imaged by bombarding them with a Cs- ion beam focused to a spot size of ca 100 – 150 nm The secondary molecular ions 12C2 -, 13C12C-, 12C14N- and 12C15N- were collected simultaneously in electron multiplier detectors at a mass
- H. N0 Floor : City Village 216 Gurugram Sector Ward : 15 . . .
Affidavit cum Declaration of Mr Rajesh Thakur duly authorized by the promoter of the proposed project, vide his authorization dated 12 07 2025
- RS 3 PA Limousine - media. audi. com
Breite Ellbogenraum Elbow width * maximaler Kopfraum Maximum headroom Angaben in Millimeter Dimensions in millimeters Angabe der Abmessungen bei Fahrzeugleergewicht Dimensions of vehicle unloaded Bei den angegeben Werten handelt es sich um auf Datenbasis ermittelte Nominalwerte Sie basieren auf zum Zeitpunkt der Ermittlung vorliegenden Datenständen und definierter Ausstattungsvariante
- Customer Case Study Sanofi Aventis - sartorius. co. kr
Customer Challenge Sanofi’s key driver for this study was to reduce the operating costs of existing purification steps with high resin costs Regulatory concerns were to be tested by determining product quality consistency through process transfer and scale-up The feasibility of extended purifications at production scale was also determined by evaluating Resolute® BioSMB system robustness
|
|
|